• Angiotensin (1-7) Research Workflow Guide

  2026-08-23

  Build more interpretable Angiotensin (1-7) experiments by connecting Mas receptor biology with practical cell, enzymology, and preclinical workflows. This guide emphasizes peptide handling, assay controls, pathway-focused readouts, and troubleshooting for renal, inflammatory, metabolic, and neurovascular research.

• IR-820: Quantitative NIR Imaging in Living Models

  2026-08-22

  IR-820, also known as New Indocyanine Green, supports near-infrared fluorescence imaging of vascular and tumor biology. This guide focuses on experimental design, quantitative controls, and how to interpret optical signals when the dye is used alone or within nanomedicine workflows.

• CRISPR/Cas9 Targeting of ABCB1 Multidrug Resistance

  2026-08-22

  The reference study used CRISPR/Cas9 genome editing to disrupt ABCB1 in two multidrug-resistant cancer cell models, directly testing whether P-glycoprotein drives drug efflux and treatment failure. ABCB1 knockout increased intracellular doxorubicin and rhodamine 123 and restored sensitivity to several ABCB1-substrate chemotherapeutics, establishing a useful genetic framework for studying tumor multidrug resistance.

• MOF-Based mRNA Delivery: ZIF-8 and PEI

  2026-08-21

  The ChemRxiv study develops a ZIF-8 metal-organic framework strategy for encapsulating and delivering fragile mRNA, identifying polyethyleneimine incorporation as a solution to rapid cargo leakage. The formulation supported protein expression in several cell lines and preserved functional mRNA after room-temperature storage, although the findings remain pre-peer-review and require broader validation.

• Proteoform-Specific Drug Interactions in Native Membranes

  2026-08-20

  Lutomski and colleagues developed a native top-down mass spectrometry workflow that releases membrane proteins and signaling complexes directly from retina rod disc membranes, preserving links between proteoforms, lipid modifications, and interactions. The study reveals proteoform-dependent G-protein assembly and differential off-target binding of PDE5 inhibitors to retinal PDE6, providing a framework for evaluating drug selectivity in native membrane environments.

• EZ Cap™ Cy5 EGFP mRNA: Dual-Readout Guide

  2026-08-20

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is a Cy5-labeled mRNA reporter that separates delivery tracking from EGFP translation readout. Its Cap1 structure, 5-moUTP chemistry, defined formulation, and dual fluorescence support an mRNA delivery and translation efficiency assay when interpreted with appropriate controls.

• Idoxuridine: A Translational Lens on Viral DNA Synthesis

  2026-08-19

  Idoxuridine, also known as 5-iodo-2'-deoxyuridine, offers translational researchers a mechanism-proximal way to interrogate viral DNA synthesis inhibition. This thought-leadership perspective connects assay design, compound handling, human-relevant validation, and strategic decision-making while using the tomivosertib DRG study as a framework for linking molecular target engagement to functional biology.

• Q-VD(OMe)-OPh in Apoptosis Assay Workflows

  2026-08-19

  Q-VD(OMe)-OPh helps researchers distinguish caspase-dependent apoptosis from ferroptosis, autophagy, and other stress responses in demanding cell models. This practical guide covers dose design, combination-treatment controls, differentiation studies, neuroprotection workflows, and troubleshooting.

• Ceramides Drive RGNNV Infection Through Autophagy

  2026-08-18

  Zhang and colleagues used global lipidomics and functional perturbation assays to show that red-spotted grouper nervous necrosis virus reshapes host sphingolipid metabolism, with ceramide accumulation supporting viral replication. The study links capsid-protein-associated ceramide remodeling to autophagy and identifies ceramide synthesis as a potential intervention point in fish nodavirus disease.

• SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis

  2026-08-18

  The reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced renal fibrosis and inflammation. Using AZ505 and LLY507 in animal and tubular epithelial cell models, the authors connect SMYD2 inhibition with reduced epithelial-mesenchymal transition, extracellular matrix accumulation, inflammatory signaling, and Smad3/STAT3 activation.

• NLRP10, Keratinocyte Survival, and AD Barrier Function

  2026-08-17

  The reference study identifies NLRP10 as a regulator of epidermal homeostasis that supports keratinocyte survival, p63-dependent differentiation, and barrier integrity in atopic dermatitis. Its combination of patient-sample analysis, air-lift human skin equivalents, and mechanistic investigation of caspase-8 and p63 provides a useful framework for connecting genetic susceptibility with tissue-level barrier dysfunction.

• MG-262 for Proteasome and Muscle Proteostasis

  2026-08-17

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) enables reversible, cell-permeable disruption of proteasome chymotryptic activity for mechanistic studies of ubiquitin accumulation, apoptosis, and cell-cycle control. Paired with the CMA reporter strategy used in recent skeletal-muscle research, it helps distinguish proteasomal stress from lysosomal proteostasis responses.

• 0.4% Trypan Blue Solution: Practical Guide

  2026-08-16

  0.4% Trypan Blue Solution supports rapid cell viability measurement, cell counting, and live/dead cell discrimination by staining cells with compromised membranes. It is intended for controlled research workflows, including selected cytotoxicity assays, but not for diagnostic, clinical, or medical use.

• Fluorouracil Workflows for Solid Tumor Research

  2026-08-15

  Build more reproducible Fluorouracil assays by combining concentration–time profiling with orthogonal measurements of DNA synthesis, viability, and apoptosis. This workflow also shows how findings from Wnt/β-catenin research can inform hypothesis-driven colon and breast cancer research without overstating combination effects.

• MMP7, EMT, and Liver Fibrosis in Biliary Atresia

  2026-08-14

  A 2026 study identifies MMP7 as a mechanistic driver of biliary atresia-associated liver fibrosis by cleaving E-cadherin and promoting β-catenin nuclear translocation during epithelial–mesenchymal transition. By integrating patient samples, transcriptomic analysis, biliary epithelial cell experiments, and a chronic mouse model, the work connects a clinical biomarker with a potentially actionable fibrotic pathway.

8072 records 1/539 page Next 12345 下5页 Last page